Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1993 Jul 31;307(6899):278–279. doi: 10.1136/bmj.307.6899.278

Aspirin and colorectal cancer.

A Paganini-Hill
PMCID: PMC1678580  PMID: 8374370

Full text

PDF
278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DeRubertis F. R., Craven P. A., Saito R. 16,16-Dimethyl prostaglandin E2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin. Gastroenterology. 1985 Nov;89(5):1054–1063. doi: 10.1016/0016-5085(85)90209-4. [DOI] [PubMed] [Google Scholar]
  2. Han T., Nemoto T., Ledesma E. J., Bruno S. Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients. Int J Immunopharmacol. 1983;5(1):11–15. doi: 10.1016/0192-0561(83)90066-8. [DOI] [PubMed] [Google Scholar]
  3. Kune G. A., Kune S., Watson L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988 Aug 1;48(15):4399–4404. [PubMed] [Google Scholar]
  4. Logan R. F., Little J., Hawtin P. G., Hardcastle J. D. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ. 1993 Jul 31;307(6899):285–289. doi: 10.1136/bmj.307.6899.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Narisawa T., Hermanek P., Habs M., Schmähl D. Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J Cancer Res Clin Oncol. 1984;108(2):239–242. doi: 10.1007/BF00402475. [DOI] [PubMed] [Google Scholar]
  6. Paganini-Hill A., Chao A., Ross R. K., Henderson B. E. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989 Nov 18;299(6710):1247–1250. doi: 10.1136/bmj.299.6710.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Paganini-Hill A., Hsu G., Ross R. K., Henderson B. E. Aspirin use and incidence of large-bowel cancer in a California retirement community. J Natl Cancer Inst. 1991 Aug 21;83(16):1182–1183. doi: 10.1093/jnci/83.16.1182-a. [DOI] [PubMed] [Google Scholar]
  8. Paganini-Hill A., Hsu G., Ross R. K., Henderson B. E. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1992 May 7;326(19):1290–1291. [PubMed] [Google Scholar]
  9. Peto R., Gray R., Collins R., Wheatley K., Hennekens C., Jamrozik K., Warlow C., Hafner B., Thompson E., Norton S. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988 Jan 30;296(6618):313–316. doi: 10.1136/bmj.296.6618.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Prescott L. F. Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs. 1982 Jan-Feb;23(1-2):75–149. doi: 10.2165/00003495-198223010-00004. [DOI] [PubMed] [Google Scholar]
  11. Thun M. J., Namboodiri M. M., Heath C. W., Jr Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593–1596. doi: 10.1056/NEJM199112053252301. [DOI] [PubMed] [Google Scholar]
  12. Verma A. K., Ashendel C. L., Boutwell R. K. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1980 Feb;40(2):308–315. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES